Joanna Carr
Supartz Knee Injection – All About the Treatment
Viscosupplementation, a minimally invasive treatment for osteoarthritis, has seen significant market growth. It was valued at $4.4 billion in 2021 and...
Joanna Carr
Supartz Dosage – Information for Practitioners
Patient safety in healthcare is a paramount concern, with statistics showing that around 1 in every 10 patients experience adverse effects during care...
Joanna Carr
Supartz Side Effects – What to Expect
Injectable treatments for knee pain have become a cornerstone in managing osteoarthritis, with a 2023 study revealing that a single injection of a hig...
Joanna Carr
Supartz vs Euflexxa – Which is Better?
Hyaluronic acid (HA), a key component of joint fluid, has been extensively studied for its role in treating knee osteoarthritis. A 2023 study found th...
Joanna Carr
Supartz vs. Synvisc – Comparing Viscosupplementation Treatments
Osteoarthritis, a common joint disease affecting the aging population, results from gradual cartilage breakdown. As cartilage wears out, bones come in...
Joanna Carr
Cingal Monovisc – Comparing OA Treatments
Osteoarthritis (OA) is a degenerative joint condition affecting over 528 million people worldwide, with the knee being the most frequently affected jo...
Joanna Carr
Cingal Hyaluronic Acid – About the Key Ingredient
Hyaluronic acid is a naturally occurring substance in the human body known for its remarkable ability to retain moisture, holding up to 1,000 times it...
Joanna Carr
Cingal FDA Approval – Is the OA Treatment Safe?
According to the World Health Organization, about 528 million people worldwide suffer from osteoarthritis (OA). With a high number of patients, this d...
Joanna Carr
Cingal Injection – All About The OA Treatment
Viscosupplementation, a treatment for knee osteoarthritis, has been systematically reviewed for its effectiveness and safety, revealing its potential ...
Joanna Carr
Dispelling the Myths: Debunking Common Misconceptions About Orthovisc
Osteoarthritis is typically linked to aging, but did you know it can also affect the younger population? While the majority of patients with osteoarth...
Joanna Carr
Orthovisc Injection: What Happens Next?
According to the latest numbers from the World Health Organization (WHO), a staggering 528 million people globally struggle with osteoarthritis. This ...
Joanna Carr
Beyond the Lab: Orthovisc and Biotechnology Advancements
According to the Global Osteoarthritis Patient Perception Survey (GOAPPS), more osteoarthritis (OA) patients seek additional treatments to manage join...
Other Categories
Aliaxin
Alidya
Bellast
Belotero
Biorepeel
Botox
Botulax
Botulinum Toxins
Business Growth
Cimzia
Crespine
Cytocare
Depo Provera
Dermal Fillers
Dermalax
Dr Cyj
Durolane
Dysport
Ejal 40
EMLA
Euflexxa
Eylea
Filorga
Gardasil
General
Harmonyca
Hyacorp
Hyafilia
Hyalgan
Hymovis
Industry News
Innotox
Intraline
Jalupro
Jaydess
Juvederm
Lanluma
Lemon Bottle
Liporase
Lumigan
Meditoxin
Mirena
Monovisc
Nabota
Neauvia
Neuramis
Nexplanon
Nucleofill
Orencia
Orthovisc
Ozempic
Perfectha
Plasmolifting
Plinest
Powerfill
Professionals
Profhilo
Prolia
Radiesse
Rejuran
Remicade
Restylane
Revanesse
Revofil
Rheumatology
Saxenda
Sculptra
Silhouette Threads
Skin
Skin care
SoftFil
Stylage
Sunekos
Synvisc
Vabysmo
Viscoderm
VOM Filler
Wegovy
Weight Loss
Xeomin